Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

NEW YORK, Feb. 13, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

http://www.reportlinker.com/p01095481/2013-Analysis-of-the-Global-Cancer...

This new report from Venture Planning Group provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.

Table of Contents

I. Worldwide Business Environment

II. Worldwide Market Structure

III. Major Current And Emerging Cancer Diagnostic Tests

1. Introduction2. Tumor Marker Classification3. ACTH4. Alpha-Fetoprotein (AFP)5. Beta-2 Microglobulin6. CA 15-3/27.297. CA 19-98. CA-1259. Calcitonin10. Carcinoembrionic Antigen (CEA)11. Estrogen and Progesterone Receptors12. Ferritin13. Gastrin14. Human Chorionic Gonadotropin (HCG)15. Insulin16. NSE17. Occult Blood18. PAP Smear/HPV19. Prostatic Acid Phosphatase (PAP)20. Prostate-Specific Antigen (PSA)21. Squamous Cell Carcinoma Antigen (SCC)22. T and B Lymphocytes23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor Markers- ADA- B-Protein- PNP- 5'-Nucleotidase 27. Oncogenes- Abl/abl-bcr- AIB1- BCL-2- BRCA1- CD44- C-fos- C-myb- C-myc- CYP-17- Erb-B- HPC1- N-myc- P40- P51- P53- PIK3CA- PTI-1- Ras- Reg- Sis- Src28. Polypeptide Growth Factors- Basic Fibroblast Growth Factor- Beta-TGF- Cachectin (TNT)- Calmodulin- ECFR- Nerve Growth Factor (NGF)- Epidermal Growth Factor (EGF)- Ornithine Decarboxylase- Transferrin- Transforming Growth Factor-Alpha 29. Ectopic Hormones30. Colony Stimulating Factors31. Lymphokines- Alpha-Interferon- B Cell Growth Factors- B Cell Growth Factor (BCGF)- Gamma-Interferon- Interleukin-1 (IL-1)- Macrophage Activating Factor32. Immunohistochemical Stains33. Emerging Tumor Markers- N-Acetylglucosamine- Actin- Alpha-Actin - Antineuronal Antibodies- 7B2- B72.3- Bax- BCD-F9- BLCA-4- Blood Group Antigens A,B,H- CA 50- CA 72-4/TAG-72- CA 195- CA-242- CA-549- CAM 26- CAR-3- Cathepsin-D- Chromogranin A and B- Cluster 1 Antigen- Cluster-5/5A Antigen- CTA- CU18- DR-70- DU-PAN-2- Endometrial Bleeding Associated Factor- Endostatin- Epithelial Membrane Antigen- Feulgen Hydrolysis- Fibronectin- FSH- (1->3)-L-fucosyltransferase- Gastrin-Releasing Peptide (GRP)- GDCFP-15- Glucagon- Glycoamines- H23- Her-2- Human Carcinoma Antigen- HPA- HSP27- Intermediate Filaments- Cytokeratins/CK18/Cyfra 21-1- Desmin- Gliofibrillary Acid Protein- Neurofilaments- Vimentin- KA 93- Kinases- KP16D3- LAI- Leukocyte Common Antigen- Lewis Antigens- Lysophosphatidic Acid (LPA)- Ma 695/Ma 552- MABDF3- MAG- ME1- Minactivin- MN/CA9- MSA- Mucin Cancer Antigen (MCA)- Multiple Tumor Suppressor 1- Myosin- NEA-130- NMP22- OA-519- Opiod Peptides- P-glycoprotein- Pancreatic Oncofetal Antigen (POA)- Placental Lactogen- PR92- Proliferative Index, Ki-67- Px- RB Inactivation/Deletion- Ret- SCCL 175- Selectin- Sialic Acid- Sialyl SSEA-1/SLX- SN10- Somatostatin- TA-90- TABA- Tachykinin- TAG 12- TPS- Troponin- Tubulin- VCAM- VEGF- Villen

IV. Instrumentation Review:

Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Horiba, Inverness/Alere, J&J, Olympus, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers

V. Current and Emerging Technologies

1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Radioimmunoassay (RIA)c. Enzyme Immunoassays (EIA)- Overview- ELISA- Immunofiltration- Particle-Membrane Capture Immunoassay- Enzyme Amplificationd. Fluorescent Immunoassayse. Luminescence- Chemiluminescence- Bioluminescencef. Latex Agglutinationg. ImmunoprecipitationH. Affinity Chromatographue. Liposome Flow-Injection Immunoassay3. Molecular Diagnosticsa. Technology Overviewb. Amplification Methods- PCR- DAP-PCR- Immuno-PCR- QC-PCR- CAR- DNA- HPA- LCR- NASBA- QBR- SDA- 3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. Acute Lymphoblastic Leukemia (ALL)d. Malignant Lymphomas Lymphoid Malignanciese. Chronic Lymphocytic Leukemia (CLL)f. Solid Cancersg. Chromosomal Translocation and Oncogenes5. Artificial Intelligence6. Flow Cytometry7. Two Dimensional Gel Electrophoresis (2-DGE)8. Biosensors9. Competing/Complementing Technologiesa. CTb. MRIc. NMRd. PETe. Photonics Spectroscopy

VI. Competitive Profiles

- Abbott- AdnaGen- Applied Gene Technologies- Beckman Coulter/Danaher- Becton Dickinson- Biomedical Diagnostics- bioMerieux- Bio-Rad- CellSearch- Cepheid- Dako- Decode- Diadexus- Diagnocure- Diasorin- Eiken Chemical- Enterix- Enzo Biochem- Epigenomics- Exact Sciences- Fujirebio- Gen-Probe- Guided Therapeutics- Hologic- Kreatech- Kyowa Medex- Life Technologies- Mackay Life Sciences- Myriad Genetics- Nanogen Elitech- Nuvelo- OncoLab- Ortho-Clinical Diagnostics- Panacea Pharmaceuticals- Polartechnics- Polymedco- PreMD- Qiagen/Ipsogen- Radient Pharmaceuticals- Roche- Scienion- Sequenom- Siemens Healthcare- Takara Bio- Targeted Diagnostics & Therapeutics- Tosoh - Vermillion/Correlogic Systems- Wako Pure Chemicals- Wallac/PE- Zila

Appendixes: Major Universities and Research Centers Developing

Cancer Diagnostic Technologies and Applications

List of Tables

Tumor Marker Classification

Major Companies Developing or Marketing

ACTH Tests

Major Companies Developing or Marketing

AFP Tests

Major Companies Developing or Marketing

Beta-2 Microglobulin Tests

Major Companies Developing or Marketing

CA 15-3/27.29 Tests

Major Companies Developing or Marketing

CA 19-9 Tests

Major Companies Developing or Marketing

CA 125 Tests

Major Companies Developing or Marketing

Calcitonin Tests

Major Companies Developing or Marketing

CEA Tests

Major Companies Developing or Marketing

Estrogen Receptor Tests

Major Companies Developing or Marketing

Progesterone Receptor Tests

Major Companies Developing or Marketing

Ferritin Tests

Major Companies Developing or Marketing

Gastrin Tests

Major Companies Developing or Marketing

HCG Tests

Major Companies Developing or Marketing

Insulin Tests

Major Companies Developing or Marketing

NSE Tests

Major Companies Developing or Marketing

Occult Blood Tests

Major Companies Developing or Marketing

PAP Smear/HPV Tests

Major Companies Developing or Marketing

PAP Tests

Major Companies Developing or Marketing

PSA Tests

Major Companies Developing or Marketing

Lymphocyte Subclassification Tests

Biochemical Markers Potential Applications

In Cancer Diagnosis

Oncogenes Potential Applications

In Cancer Diagnosis

Major Companies Developing or Marketing

Oncogene Tests

Growth Factors Potential Applications

In Cancer Diagnosis

Colony Stimulating Factors Potential

Applications in Cancer Diagnosis

Lymphokines Potential Applications

In Cancer Diagnosis

Immunohistochemical Stains Potential

Applications in Cancer Diagnosis

Worldwide, All Market Segments, Laboratories

Performing Cancer Diagnostic Testing By Country

Worldwide, All Market Segments, Cancer Diagnostic

Test Volume Forecasts By Country

Worldwide, All Market Segments, Cancer Diagnostics

Sales Forecasts By Country

To order this report:In_Vitro_Diagnostic Industry:

2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

 

SOURCE Reportlinker

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
The cloud market growth today is largely in public clouds. While there is a lot of spend in IT departments in virtualization, these aren’t yet translating into a true “cloud” experience within the enterprise. What is stopping the growth of the “private cloud” market? In his gen...
The initial debate is over: Any enterprise with a serious commitment to IT is migrating to the cloud. But things are not so simple. There is a complex mix of on-premises, colocated, and public-cloud deployments. In this power panel at 18th Cloud Expo, moderated by Conference Ch...
"A lot of times people will come to us and have a very diverse set of requirements or very customized need and we'll help them to implement it in a fashion that you can't just buy off of the shelf," explained Nick Rose, CTO of Enzu, in this SYS-CON.tv interview at 18th Cloud Expo...
It is one thing to build single industrial IoT applications, but what will it take to build the Smart Cities and truly society changing applications of the future? The technology won’t be the problem, it will be the number of parties that need to work together and be aligned in t...
In his general session at 18th Cloud Expo, Lee Atchison, Principal Cloud Architect and Advocate at New Relic, discussed cloud as a ‘better data center’ and how it adds new capacity (faster) and improves application availability (redundancy). The cloud is a ‘Dynamic Tool for Dyna...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE